Mark G. Malkin

Suggest Changes
Learn More
BACKGROUND AND OBJECTIVES Venous thromboembolism (VTE) occurs in 20-30% of patients with malignant glioma per year of survival. We tested the efficacy of long-term dalteparin low-molecular-weight(More)